STAT

Opinion: Protect patient access to drug infusions administered in physician offices

Congress should reject a policy that would jeopardize access to important drug treatments, shift care to the more expensive hospital setting, and increase costs to patients and the Medicare program.

As gastroenterologists, we treat patients in Portland, Ore., and Des Moines, Iowa, with challenging disorders like Crohn’s disease and ulcerative colitis who sometimes need infusions of medications. Legislation before Congress could make it difficult — and potentially impossible — for us to provide this important care in our medical practices.

That could force our patients to go to hospitals

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.

Related Books & Audiobooks